Senator David Vitter had some things to say to the FDA yesterday, in response to their recommendation to revoke the approval of the drug Avastin
Center for Studying Health System Change: (1) publications on insurance coverage and costs, (2) publications on health care markets, (3) all publications. That should be
Go back through nearly a year of posts, and I bet you won’t find many that talk about my experiences with patients. You might not
With two girls under six in my house, Silly Bandz are all the rage. According to the Wall Street Journal, they’re the latest little kid
The leadoff article in the Competition Policy International Journal‘s (paywall) recent “focus issue” on behavioral economics is a primer on the literature regarding systematically irrational
Per Avik Roy, the study we’ve been discussing is up online. Unfortunately, it’s behind a paywall, so most of you won’t be able to see
This post is part of a multi-post series on the filibuster in the U.S. Senate. An index to all other posts in the series, as
Racial and ethnic disparities in health care and insurance is no where near my expertise. But I have questions, such as, “Why are so many
I remember this one moment back in the midst of health care reform when I was sitting in a radio studio, feeling pretty glum about
You hear all this talk about whether or not people approve of the Affordable Care Act, and you start to believe that somehow the exact
The following is a re-post of my most recent Kaiser Health News column. It has been cited in the 4 August 2010 edition of Health
